Clinical Trial Update: A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating evogliptin for type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Evogliptin (evogliptin)

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED